Form 8-K - Current report:
SEC Accession No. 0001213900-16-011368
Filing Date
2016-03-07
Accepted
2016-03-07 15:55:13
Documents
2
Period of Report
2016-03-02
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k030216_immucellcorp.htm 8-K 18234
2 LETTER FROM BAKER NEWMAN & NOYES, LLC f8k030216ex16i_immucellcorp.htm EX-16.1 3398
  Complete submission text file 0001213900-16-011368.txt   22722
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 161488392
SIC: 2835 In Vitro & In Vivo Diagnostic Substances